Riskpilot← Back to searchSign inGet full accessUrolund AB
ABActiveOrg 5566974795Kabbarpsvägen 3Medical specialists activities · NACE 8622Est. 20061 employees
Revenue 2025
SEK 4M
+9% vs 2024
EBITDA margin
18.4%
+81% vs 2024
Equity ratio
70.9%
Financial strength
Net profit 2025
SEK 522K
+40% vs 2024
| Revenue | SEK 4M | +9% |
| EBITDA | SEK 729K | +81% |
| Net profit | SEK 522K | +40% |
| Total assets | SEK 2,2M | +20% |
| Equity | SEK 1,6M | +9% |
| Employees | 1 | — |
Legal name
Urolund AB
Org number
5566974795
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
26 januari 2006
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva specialistläkarvård, handel med värdepapper, förvalta fast och lös egendom samt silversmide samt idka därmed förenlig verksamhet.
Address
Kabbarpsvägen 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 1 821 | 1 945 | 3 333 | 3 756 | 3 656 | 3 702 | 3 644 | 3 954 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 454 | 453 | 559 | 737 | 821 | 656 | 626 | 589 | 402 | 729 |
| Depreciation & amort. | −68 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 386 | 453 | 559 | 737 | 821 | 656 | 626 | 589 | 402 | 729 |
| Net financials | −8 | −1 | — | — | — | −1 | −1 | 1 | 67 | −117 |
| Profit before tax | 378 | 452 | 559 | 737 | 921 | 656 | 626 | 590 | 469 | 673 |
| Tax | −84 | −100 | −124 | −164 | −198 | −141 | −130 | −122 | −97 | −151 |
| Net profit | 294 | 352 | 435 | 573 | 723 | 515 | 496 | 468 | 372 | 522 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 639 | 619 | 766 | 1 000 | 1 432 | 1 663 | 1 803 | 2 023 | 1 867 | 2 237 |
| Equity | 456 | 457 | 542 | 715 | 938 | 1 153 | 1 369 | 1 497 | 1 459 | 1 587 |
| Long-term debt | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 64 | 62 | 123 | 185 | 493 | 510 | 434 | 526 | 408 | 650 |
| Total debt | 83 | 62 | 123 | 185 | 493 | 510 | 434 | 526 | 408 | 650 |
EBITDA margin
18.4%
This company
15.8%
Market median
+16% vs market
20162025
Equity ratio
70.9%
This company
38.2%
Market median
+86% vs market
20162025
Return on equity
32.9%
This company
18.4%
Market median
+79% vs market
20162025
Net profit margin
13.2%
This company
8.1%
Market median
+63% vs market
20162025
Asset turnover
1.77×
This company
1.12×
Market median
+58% vs market
20162025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BH Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Urolund AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Håkan Rylander | Audit | 0 companies |
| Jan Niclas Lundin | Board of Directors | 0 companies |
| Anna Catarina Lundin | Deputy Board Member | 0 companies |